loadpatents
name:-0.020877122879028
name:-0.01211404800415
name:-0.00062298774719238
Thomas; Russell J. Patent Filings

Thomas; Russell J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thomas; Russell J..The latest application filed is for "piperazine derivatives and methods of use".

Company Profile
0.15.18
  • Thomas; Russell J. - Siena N/A IT
  • Thomas; Russell J - Siena IT
  • Thomas; Russell J. - Oxfordshire GB
  • Thomas; Russell J. - Oxford GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Piperazine derivatives and methods of use
Grant 8,946,227 - Magar , et al. February 3, 2
2015-02-03
SirT inhibitors that bind to NAD
Grant 8,486,990 - Napper , et al. July 16, 2
2013-07-16
Piperazine Derivatives And Methods Of Use
App 20130143893 - Magar; Sharad ;   et al.
2013-06-06
Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor
Grant 8,415,480 - Page , et al. April 9, 2
2013-04-09
Piperazine-2-carboxamide derivatives
Grant 8,404,690 - Page , et al. March 26, 2
2013-03-26
Therapeutic compounds and uses thereof
Grant 7,897,765 - Distefano , et al. March 1, 2
2011-03-01
Pyridinyl acetonitriles
Grant 7,855,212 - Schwarz , et al. December 21, 2
2010-12-21
Piperazine derivatives and methods of use
Grant 7,754,722 - Magar , et al. July 13, 2
2010-07-13
SirT Inhibitors That Bind to NAD
App 20090306168 - Napper; Andrew ;   et al.
2009-12-10
Therapeutic Compounds And Uses Thereof
App 20090264410 - Distefano; Peter ;   et al.
2009-10-22
Thiazolidine Carboxamide Derivatives As Modulators Of The Prostaglandin F Receptor
App 20090215749 - PAGE; Patrick Naxos ;   et al.
2009-08-27
Therapeutic compounds and uses thereof
Grant 7,504,506 - Distefano , et al. March 17, 2
2009-03-17
Triazoles as oxytocin antagonists
Grant 7,468,385 - Quattropani , et al. December 23, 2
2008-12-23
Thiazolidine Carboxamide Derivatives As Modulators Of The Prostaglandin F Receptor
App 20080255094 - PAGE; Patrick Naxos ;   et al.
2008-10-16
Pharmaceutically active pyrrolidine derivatives
App 20080167318 - Halazy; Serge ;   et al.
2008-07-10
Benzimidazole Acetonitriles
App 20070203134 - Schwarz; Matthias ;   et al.
2007-08-30
Benzoxazole acetonitriles
App 20070185104 - Schwarz; Matthias ;   et al.
2007-08-09
Piperazine-2-carboxamide derivatives
App 20070142391 - Page; Patrick ;   et al.
2007-06-21
Pharmaceutically active pyrrolidine derivatives
Grant 7,211,601 - Halazy , et al. May 1, 2
2007-05-01
Pyridinyl acetonitriles
App 20070060594 - Schwarz; Matthias ;   et al.
2007-03-15
Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
App 20060229343 - Schwarz; Matthias ;   et al.
2006-10-12
Piperazine Derivatives and Methods of Use
App 20060223813 - Magar; Sharad ;   et al.
2006-10-05
Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
Grant 7,115,639 - Schwarz , et al. October 3, 2
2006-10-03
Methods of treating a disorder
App 20060074124 - Napper; Andrew ;   et al.
2006-04-06
Sulfonamides and uses thereof
App 20050261332 - Distefano, Peter ;   et al.
2005-11-24
Methods of treating a disorder
App 20050209300 - Napper, Andrew ;   et al.
2005-09-22
Therapeutic compounds and uses thereof
App 20050187237 - Distefano, Peter ;   et al.
2005-08-25
Triazoles as oxytocin antagonists
App 20050187275 - Quattropani, Anna ;   et al.
2005-08-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed